Global Hospital Care Partnering 2016-2023: Deal Trends, Players and Financials

DUBLIN, June 6, 2023 /PRNewswire/ -- The "Global Hospital Care Partnering 2016-2023: Deal Trends, Players and Financials" report has been added to  ResearchAndMarkets.com's offering.

Global Hospital Care Partnering 2016 to 2023 provides the full collection of hospital care disease deals signed between the world's pharmaceutical and biotechnology companies since 2016.

• Trends in hospital care partnering deals
• Financial deal terms for headline, upfront and royalty by stage of development
• Hospital care partnering agreement structure
• Hospital care partnering contract documents
• Top hospital care deals by value
• Most active hospital care dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive hospital care disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering hospital care deals.

The report presents financial deal terms values for hospital care deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of hospital care dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in hospital care dealmaking since 2016 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading hospital care deals since 2016. Deals are listed by headline value. The chapter includes the top 25 most active hospital care dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to hospital care deals since 2016 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all hospital care partnering deals by specific hospital care target announced since 2016. The chapter is organized by specific hospital care therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all hospital care partnering deals signed and announced since 2016. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in hospital care partnering and dealmaking since 2016.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Hospital Care technologies and products.

Report scope

Global Hospital Care Partnering 2016 to 2023 is intended to provide the reader with an in-depth understanding and access to hospital care trends and structure of deals entered into by leading companies worldwide.

Global Hospital Care Partnering 2016 to 2023 includes:

• Trends in hospital care dealmaking in the biopharma industry since 2016
• Access to headline, upfront, milestone and royalty data
• Access to hundreds of hospital care deal contract documents
• Comprehensive access to over 1500 hospital care deal records
• The leading hospital care deals by value since 2016
• Most active hospital care dealmakers since 2016

The report includes deals for the following indications: Accident and emergency, Rehabilitation medicine, Surgery, Orthopedics, Aesthetic procedures, Transplantation, plus other Hospital Care indications.

In Global Hospital Care Partnering 2016 to 2023, available deals and contracts are listed by:

• Headline value
• Upfront payment value
• Royalty rate value
• Stage of development at signing
• Deal component type
• Technology type
• Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Hospital care Partnering 2016-2023 report provides comprehensive access to available deals and contract documents for over 1500 hospital care deals.

Analyzing actual contract agreements allows assessment of the following:

• What are the precise rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are the sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Trends in hospital care dealmaking
2.1. Introduction
2.2. Hospital care partnering over the years
2.3. Hospital care partnering by deal type
2.4. Hospital care partnering by industry sector
2.5. Hospital care partnering by stage of development
2.6. Hospital care partnering by technology type
2.7. Hospital care partnering by therapeutic indication

Chapter 3 -Financial deal terms for hospital care partnering
3.1. Introduction
3.2. Disclosed financials terms for hospital care partnering
3.3. Hospital care partnering headline values
3.4. Hospital care deal upfront payments
3.5. Hospital care deal milestone payments
3.6. Hospital care royalty rates

Chapter 4 - Leading hospital care deals and dealmakers
4.1. Introduction
4.2. Most active in hospital care partnering
4.3. List of most active dealmakers in hospital care
4.4. Top hospital care deals by value

Chapter 5 - Hospital care contract document directory
5.1. Introduction
5.2. Hospital care partnering deals where contract document available

Chapter 6 - Hospital care dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by hospital care therapeutic target

Companies Mentioned

• 3D-Side
• 3D Systems
• 3M
• 3SBio
• 4WEB Medical
• 7 Hills Pharma
• 7D Surgical
• 11 Health and Technologies
• 111
• A&E Medical
• AAP Implantate AG
• Aatru Medical
• Abbvie
• Abiomed
• Ab Medica
• Abram Scientific
• Absolute Antibody
• AbSorber
• Acacia Pharma
• Acacia Research
• Acare Medical Science
• Accelus
• Accenture
• Access Scientific
• Accord Healthcare
• Accuray
• AccuTec Blades
• Acelity
• Acell
• Acelrx Pharmaceuticals
• Acentrus Specialty
• Acerus
• ActLight
• Acuity Healthcare
• Acuna-Fombona
• AdaptHealth
• Adaptimmune
• ADAS 3D Medical
• Adeor Medical
• Adhezion Biomedical
• ADIENNE Pharma & Biotech
• Admedus
• Advanced Aesthetic Technologies
• Advanced Cooling Therapy
• Advanced Guidance Technologies
• Advanced IT Concepts
• Advanced Ultrasound Systems
• Advantage Medical
• Advanz Pharma
• AdventHealth
• Aerapy
• Aerobiotix
• Aesculap
• Aesthetic Management Partners
• Aesthetic Medical International
• Aethlon Medical
• Aetna
• Agadia Systems
• AgeX Therapeutics
• Agiliti
• AgNovos Healthcare
• Aguettant
• Aidoc
• Aiforia Technologies
• AirStrip Technologies
• AirXpanders
• Aitrics
• Akari Therapeutics
• Akers Biosciences
• Akumin
• ALASTIN Skincare
• Alfasigma
• Algeos
• AliMed
• AliveCor
• ALK-Abello
• Allegheny Technologies
• Allenex
• Allergan
• Allergan Aesthetics
• Alliance Medical
• Allied Centre for Medical Excellence
• Alliqua Biomedical
• Alloksys Life Sciences
• AlloSource
• Almirall
• Alnylam Pharmaceuticals
• Alpha Imaging
• Alphamedix
• Alphatec Spine
• Altan Pharma
• Altaris Capital Partners
• Altasciences
• Altitude International
• Alume Biosciences
• Alvarado Hospital Medical Center
• Alyzen Medical Physics
• Amag Pharmaceuticals
• Ambra Health
• Ambu
• Amedica
• Amedisys
• Amendia
• Amend Surgical
• American Academy of Orthopaedic Surgeons
• American College of Chest Physicians
• American Health Imaging
• American Medical Technologies
• American Society for Aesthetic Plastic Surgery
• American Well
• Amerinet
• AmerisourceBergen
• Amgen
• AMI
• Amicrobe
• AMNIOX
• Amomed Pharma
• Amplifire
• Amplyx Pharmaceuticals
• Ancestry
• Anelixis Therapeutics
• Anelto
• Angiodynamics
• Angion Biomedica
• Angsana Molecular & Diagnostics
• Anika Therapeutics
• Anita Tecnica
• ANP Technologies
• Antares Pharma
• Anthem
• Antibe Therapeutics
• Apex Physics Partners
• ApiFix
• Apollo Endosurgery
• Appalachian Regional Healthcare
• Apple
• Applied DNA Sciences
• Applimotion
• APR Medtech
• Aptevo Therapeutics
• Archer Capital
• Arch Therapeutics
• argenx
• Argon Medical Devices
• Aridea Solutions
• Aridis Pharmaceuticals
• Arjo
• Arkansas Childrens Hospital
• Armaghan Salamat Kish
• Armis Biopharma
• Armor
• Arsenal Medical
• Artegraft
• Arteriocyte Medical Systems
• Arthrex
• Arthrosurface
• ARxIUM
• Asahi Kasei
• Ascendum
• Ascension
• Ascension Saint Thomas
• Asensus Surgical
• ASICO
• AskAt
• Asklepios Group
• Aspen Surgical Products
• Assure
• Astarte Medical
• Astellas Pharma
• AstraZeneca
• Asys
• Athersys
• Atlas Lift Tech
• ATL Technology
• Atnahs Pharma
• Atos Medical
• Atricure

For more information about this report visit https://www.researchandmarkets.com/r/8b9hgn

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets